Latest Observability News

Gladiator Resources has initiated the process to list on the US OTC Markets, aiming to enhance visibility and liquidity among North American investors as part of its rare earth elements growth strategy.

PYC Therapeutics has reported promising safety data from the initial phase of its clinical trial for PYC-003, an RNA therapy targeting the root cause of Polycystic Kidney Disease. The findings, presented at the ANZSN conference, highlight the drug’s tolerability in healthy volunteers, paving the way for further clinical development.

Argenica Therapeutics reported a 34% revenue increase driven by R&D incentives but saw losses widen by 31% due to intensified clinical trial activity. The company is progressing its ARG-007 Phase 2 stroke trial and engaging with the FDA to lift a clinical hold.

Sipa Resources has reported exceptional high-grade gold intersections from its maiden drilling at the Nuckulla Hill Project in South Australia, revealing promising exploration upside along the Yarlbrinda Shear Zone. Follow-up drilling is set to test extensions and nearby prospects imminently.

New Age Exploration has verified key geological features at its Wagyu Gold Project, aligning it with the prolific Hemi mineral corridor and paving the way for expanded drilling.

Ramsay Health Care has confirmed the payment of a fully franked ordinary dividend on its perpetual preference securities, clearing prior approval conditions and setting a payment date for October 2025.

Lynas Rare Earths reports FY25 revenue growth amid profit decline, completes major capital projects, and launches a $750 million equity raise to fund its expansive Towards 2030 strategy.

Biotron Limited reported a significantly reduced net loss of $318,572 for FY2025, bolstered by a $1.27 million capital raise and a $1.81 million R&D tax rebate, as it advances clinical and preclinical antiviral programs.

humm Group has disclosed the key terms of CEO Angelo Demasi’s employment agreement, highlighting a $750,000 salary and significant incentive opportunities tied to company performance.

Ark Mines reports its Stage-3 drilling at Sandy Mitchell is ahead of schedule, aiming to nearly quintuple its measured mineral resource and fuel a pivotal Pre-Feasibility Study.

Karoon Energy has significantly upgraded its Baúna Project 2P Reserves by 35%, extending the field’s economic life by seven years to 2039, driven by the recent FPSO acquisition and improved reservoir performance.

Race Oncology Limited reported a significantly reduced loss for FY2025, driven by key clinical trial progress and strategic leadership changes. The company advances its RC220 program with promising Phase 1 dosing milestones and strengthens its governance to support future growth.